Intensive nutritional counselling in bulimia nervosa: A role for supplementation with fluoxetine?

Australian and New Zealand Journal of Psychiatry

Volumn 31, Issue 4, 1997, Pages 514-524

  Beumont, Pierre J V ^a   Russell, Janice D ^a   Touyz, Stephen W ^a,b   Buckley, Cathy ^a   Lowinger, Kitty ^a   Talbot, Peter ^a   Johnson, Gordon F S ^a  

^a Department of Psychology ^*  (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bulimia nervosa; Fluoxetine; Nutritional counselling

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BODY WEIGHT; BULIMIA; CALORIC INTAKE; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; FOOD INTAKE; HEADACHE; HUMAN; INSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COUNSELING; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030767583     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.3109/00048679709065073     Document Type: Article

References (35)

1. Walsh BT, Devlin MJ. Psychopharmacology of anorexia nervosa, bulimia nervosa, and binge eating. In: Bloom FE and Kupfer DJ eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995.
2. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Archives of General Psychiatry 1990; 47:149-157.
3. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long term outcome of antidepressant treatment for bulimia nervosa. American Journal of Psychiatry 1991; 148:1206-1212.
4. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Archives of General Psychiatry 1992; 49:139-147.
5. Fava M, Herzog DB, Hamburg P, Riess H, Anfang S, Rosenbaum JF. Long-term use of fluoxetine in bulimia nervosa: a retrospective study. Annals of Clinical Psychiatry 1990; 2:53-56.
6. Pyle RL, Mitchell JE, Echert ED, Hatsukami D, Pomeroy C, Zimmerman R. Maintenance treatment and 6 month outcome for bulimia patients who respond to initial treatment. American Journal of Psychiatry 1990; 147:871-875.
7. Fairburn CG. A cognitive behavioural approach to the management of bulimia. Psychological Medicine 1981; 11:707-711.
8. Fairburn CG, Marcus MD, Wilson GT. Cognitive behaviour therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. In: Fairburn CG, Wilson GT, eds. Binge eating: nature, assessment and treatment. New York: Guilford Press, 1993:361-404.
9. Fairburn CG. Short term psychological treatments for bulimia nervosa. In: Brownell KD, Fairburn CG eds. Eating disorders and obesity: a comprehensive textbook. New York: Guilford Press, 1995:344-348.
10. Beumont PJV, Touyz SW. The nutritional management of anorexia and bulimia nervosa. In: Fairburn CG, Wilson GT eds. Binge eating: nature, assessment and treatment. New York: Guilford Press, 1993:306-312.
11. Laessle RG, Beumont PJV, Butow P et al. A comparison of nutritional management with stress management in the treatment of bulimia nervosa. British Journal of Psychiatry 1991; 159:150-261.
12. Mitchell JE, Raymond N, Specker S. A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. International Journal of Eating Disorders 1993; 14:229-247.
13. Agras WS, Rossiter EM, Arnow B et al. Pharmacologic and cognitive-behavioural treatment for bulimia nervosa: a controlled comparison. American Journal of Psychiatry 1992; 149:82-87.
14. Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebmk D. Comparison of cognitive-behaviour therapy and disimpramine in the treatment of bulimia nervosa. Behaviour Research and Therapy 1994; 32:37-45.
15. Fichter MM, Liebl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991; 24:1-7.
16. Hamilton MA. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23:56-65.
17. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychological Medicine 1982; 12:871-878.
18. Garner DM. Eating disorder inventory: 2. Professional manual. Odessa, FL: Psychological Assessment Resources, 1991.
19. Cooper PJ, Taylor MJ, Cooper Z, Fairburn CG. The development and validation of the Body Shape Questionnaire. International Journal of Eating Disorders 1987; 6:485-494.
20. Fairburn CG, Cooper Z. The Eating Disorder Examination, 12th ed. In: Fairburn CG, Wilson GT eds. Binge eating, nature, assessment and treatment. New York: Guilford Press, 1993:317-360.
21. Garner DM. Measurement of eating disorder psychopathology. In: Brownell KD, Fairburn CG eds. Eating disorders and obesity: a comprehensive handbook. New York: Guildford Press, 1995:120
22. Beumont PJV, Kopec-Schrader E, Talbot P, Touyz SW Measuring the specific psychopathology of eating disorder patients. Australian and New Zealand Journal of Psychiatry 1993; 27:506-511.
23. Therapeutic Goods Administration. Guidelines for good clinical research practice in Australia. Therapeutic Goods Administration, 1991.
24. Fairburn CG, Jones R, Peveler RC et al. Three psychological treatments for bulimia nervosa. Archives of General Psychiatry 1991; 24:629-643.
25. Pope HG, Hudson JI. The treatment of bulimia with antidepressants. Psychopharmacology 1982; 78:176-179.
26. Pope HG. Bulimia nervosa and affective disorder. International Journal of Eating Disorders 1988; 7:165-167.
27. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM. Treating bulimia with desipramine: a placebo-controlled double-blind study. Archives of General Psychiatry 1986; 43:182-186.
28. Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH. Phenelzine vs placebo in 50 patients with bulimia. Archives of General Psychiatry 1988; 45:471-475.
29. Horne RL, Ferguson JM, Pope HG Jr et al. Treatment of bulimia with bupropion: a multicenter controlled trial. Journal of Clinical Psychiatry 1988; 49:262-266.
30. Pope HG Jr, Hudson JI. Antidepressant drug therapy of bulimia: current status. Journal of Clinical Psychiatry 1986; 47:339-345.
31. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. Journal of Clinical Psychopharmacology 1984; 4:186-193.
32. Ferguson JM, Feighner JB. Fluoxetine-induced weight loss in overweight non-depressed humans. International Journal of Obesity 1987; 11:163-170.
33. Levine LR, Rosenblatt S, Bosomworth J. Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity. International Journal of Obesity 1987; 11 (suppl. 3):185-190.
34. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W. A double-blind, placebo-controlled trial of fluoxetine plus behaviour modification in the treatment of obese binge-eaters and non-binge-eaters. American Journal of Psychiatry 1990, 147:876-881.
35. Walsh BT, Wilson GT, Loeb KL et al. Medication and psychotherapy in the treatment of bulimia nervosa. American Journal of Psychiatry 1997 (in press).